Evaluation of Palliative Care for Patients With ALS and Their Caregivers
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Amyotrophic Lateral Sclerosis
Related studies linked through entity extraction aliases.
An Efficacy and Safety Study of Ravulizumab in ALS Participants
- Status
- TERMINATED
- Phase
- PHASE3
Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Tolerability, Safety and Efficacy of Sigh Breaths During NIMV in Motor Neuron Disease
- Status
- UNKNOWN
- Phase
- NA
Salivary Biomarker Discovery by Raman Spectroscopy in ALS (SalivALS)
- Status
- COMPLETED
- Phase
- N/A
Breath Stacking Technique Associated With Expiratory Muscle Training in Amyotrophic Lateral Sclerosis Patients
- Status
- TERMINATED
- Phase
- NA
RAPA-501 Therapy for ALS
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Safety and Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS)
- Status
- COMPLETED
- Phase
- PHASE1
Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Explore the Role of Gut Flora in ALS
- Status
- WITHDRAWN
- Phase
- N/A
The Efficacy and Safety of Vitamin E Mixed Tocotrienols In Patients With Amyotrophic Lateral Sclerosis (ALS)
- Status
- UNKNOWN
- Phase
- PHASE2
The Ontario Neurodegenerative Disease Research Initiative
- Status
- COMPLETED
- Phase
- N/A
Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS)
- Status
- COMPLETED
- Phase
- PHASE2
Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
- Status
- RECRUITING
- Phase
- N/A
Validation of the "ExSpiron©" in Patients With ALS
- Status
- NOT_YET_RECRUITING
- Phase
- NA
CuATSM Compared With Placebo for Treatment of ALS/MND
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
The E-health Application To Modify ORal Energy Intake and Measure Outcomes REmotely in ALS Clinical Trial (EAT MORE2)
- Status
- COMPLETED
- Phase
- N/A
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
- Status
- SUSPENDED
- Phase
- N/A